BiotechTube
Home/Gliknik/Paul Friedman, M.D.
PF

Paul Friedman, M.D.

Director

Gliknik

Therapeutic Areas

Autoimmune DiseasesOncology

Gliknik Pipeline

DrugIndicationPhase
GL-2045Autoimmune diseases (e.g., Immune Thrombocytopenia)Phase 2
GL-0719Autoimmune diseases (e.g., Cold Agglutinin Disease)Phase 2

Leadership Team at Gliknik

DB
David Block
Co-Founder & CEO
RS
Raymond Schinazi, Ph.D., D.Sc.
Board Member
View full Gliknik profile